By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Antisense Therapeutics Limited 

Level 1
10 Wallace Avenue
Toorak  Victoria  3142  Australia
Phone: 61-3-9827-8999 Fax: 61-3-9827-1166


SEARCH JOBS


Industry
Pharmaceutical






Company News
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS – Phase II Trial Results Published In The Leading Medical Journal Neurology 9/22/2014 8:49:37 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Phase II Trial Results Published In The Leading Medical Journal Neurology 9/22/2014 8:16:42 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS Further Development Plans – U.S. FDA Pre-IND Response Timing Confirmed; European Patent Allowance 9/16/2014 3:02:34 PM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Phase 2 Trial - Successful Efficacy Results 9/3/2014 11:21:14 AM
Antisense Therapeutics Limited (ANP.AX) Release: Strategy Update - ATL1103 & ATL1102 8/20/2014 9:11:33 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Dosing Completed 7/29/2014 7:45:31 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014 9:00:25 AM
Antisense Therapeutics Limited (ANP.AX) Release: ATL1103 Acromegaly Phase 2 Trial Recruitment Completed 3/21/2014 10:43:28 AM
Antisense Therapeutics Limited (ANP.AX) Selected To Present At Biotech Showcase™ 2014 1/8/2014 6:51:53 AM
Antisense Therapeutics Limited (ANP.AX) Release: Positive Results Achieved From Interim Analysis Of ATL1103 Phase II Trial 12/23/2013 9:31:41 AM
1234
//-->